Complementary or alternative therapy use and health status in systemic lupus erythematosus

Lupus

Volumn 18, Issue 2, 2009, Pages 159-163

  Alvarez Nemegyei, J ^a,b   Bautista Botello, A ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b not available   (Mexico)

Author keywords

Alternative therapies; Complementary medicine; Cumulated damage; Quality of life; Systemic lupus erythematosus

Indexed keywords

ADULT; AGED; ALTERNATIVE MEDICINE; AMERICAN INDIAN; ARTICLE; CROSS-SECTIONAL STUDY; ETHNOLOGY; HEALTH STATUS; HUMAN; MEXICO; MIDDLE AGED; PAIN; QUALITY OF LIFE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; HEALTH STATUS; HUMANS; INDIANS, NORTH AMERICAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEXICO; MIDDLE AGED; PAIN; QUALITY OF LIFE; YOUNG ADULT;

EID: 65349147056     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203308095946     Document Type: Article

References (31)

1. National Center for Complementary and Alternative Medicine. National Institutes of Health. Available at: http://nccam.nih.gov/health/whatiscam/; 2007 [access verified at: 20.09.2007].
2. Eisenberg, D, Kessler, R, Van, R, et al. Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann Intern Med 2001; 135: 344-351.
3. Desmet, P. Drug therapy: herbal remedies. N Engl J Med 2002; 347: 2046-2056.
4. Eisenberg, DM, Davis, RB, Tener, SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280: 1569-1575.
5. Ramos-Remus, C, Gutierrez-Urena, S, Davis, P. Epidemiology of complementary and alternative practices in rheumatology. Rheum Dis Clin North Am 1999; 25: 789-804.
6. Wootton, JC, Sparber, A. Surveys of complementary and alternative medicine: part IV. Use of alternative and complementary therapies for rheumatologic and other diseases. J Altern Complement Med 2001; 7: 715-721.
7. Fautrel, B, Adam, V, St-Pierre, Y, Joseph, L, Clarke, AE, Penrod, JR. Use of complementary and alternative therapies by patients selfreporting arthritis or rheumatism: results from a nationwide Canadian survey. J Rheumatol 2002; 29: 2435-2441.
8. Rao, JK, Mihaliak, K, Kroenke, K, Bradley, J, Tierney, WM, Weinberger, M. Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med 1999; 131: 409-416.
9. Lau, CS, Lo, Y, Mok, MY. The use of complementary and alternative medicines in rheumatic diseases in Chinese. Arthritis Care Res 2001; 45: S13.
10. Alvarez-Hernandez, E, Casasola-Vargas, JC, Lino-Perez, L, Vázquez-Mellado, J, Vargas, RB. [Frequency of use of complementary and alternative medicine in first-time patients of an outpatient rheumatology clinic. An analysis of 800 cases] Frecuencia de uso de medicinas complementarias y alternativas en sujetos que acuden por primera vez al servicio de reumatología. Análisis de 800 casos. Reumatol Clin 2006; 2: 183-189.
11. Ramos-Remus, C, Gamez-Nava, JL, Gonzalez-López, L, et al. Use of alternative therapies by patients with rheumatic diseases in Guadalajara, Mexico: Prevalence, beliefs and expectations. Arthritis Care Res 1998; 11: 411-418.
12. Rao, JK, Kroenke, K, Mihaliak, KA, Grambow, SC, Weinberger, M. Rheumatology patients' use of complementary therapies: results from a one-year longitudinal study. Arthritis Rheum 2003; 49: 619-625.
13. Breuer, GS, Orbach, H, Elkayam, O, et al. Use of complementary and alternative medicine among patients attending rheumatology clinics in Israel. Isr Med Assoc J 2006; 8: 184-187.
14. Moore, AD, Petri, MA, Manzi, S, et al. The use of alternativemedical therapies in patients with systemic lupus erythematosus. Trination Study Group. Arthritis Rheum 2000; 43: 1410-1418.
15. Leong, KP, Pong, LY, Chan, SP. Why lupus patients use alternative medicine. Lupus 2003; 12: 659-664.
16. Leong, KP, Pong, LY, Ng, TP, Chng, HH. The use of traditional Chinese medication in lupus patients in Singapore. APLAR J Rheumatol 1997; 1: 116-120.
17. Ramos-Remus, C, Gamez-Nava, JI, Gonzalez-Lopez, L, Suarez-Almazor, ME. Use of alternative medicine in a consecutive sample of patients with systemic lupus erythematosus. J Rheumatol 1997; 24: 2490-2491 [Letter].
18. Patavino, T, Brady, DM. Natural medicine and nutritional therapy as an alternative treatment in systemic lupus erythematosus. AlternMed Rev 2001; 6: 460-471.
19. Van Vollenhoven, RF. Dehydroepiandrosterone for the treatment of systemic lupus erythematosus. Expert Opin Pharmacother 2002; 3: 23-31.
20. Tao, X, Lipsky, PE. The Chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook F. Rheum Dis Clin North Am 2000; 26: 29-50.
21. Hilepo, JN, Belluci, AG, Mossey, RT. Acute renal failure caused by "cat's claw" herbal remedy in a patient with systemic lupus erythematosus. Nephron 1997; 77: 361 (Letter).
22. Kraus, A, Guerra-Bautista, G, Alarcon-Segovia, D. Salmonella arizona arthritis and septicemia associated with rattlesnake ingestion by patients with connective tissue diseases. A dangerous complication of folk medicine. J Rheumatol 1991; 18: 1328-1331.
23. Tan, EM, Cohen, AS, Fries, JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
24. TheMedical Outcomes Trust. SF-36.org. Available at: http://www.sf-36.org/ ; [access verified at: 20.09.2007].
25. Stoll, T, Gordon, C, Seifert, B, et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol 1997; 24: 1608-1614.
26. Gladman, D, Ginzler, E, Goldsmith, C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-369.
27. Gladman, DD, Urowitz, MB, Goldsmith, CH, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 809-813.
28. Sutcliffe, N, Clarke, AE, Gordon, C, Farewell, V, Isenberg, DA. The association of socioeconomic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology 1999; 38: 1130-1137.
29. Sutcliffe, N, Clarke, AE, Levinton, C, Frost, C, Gordon, C, Isenberg, DA. Associates of health status in patients with SLE. J Rheumatol 1999; 26: 2352-2356.
30. Clarke, AE, Petri, MA, Manzi, S, et al. An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. J Rheumatol 1999; 26: 1500-1511.
31. Wahner-Roedler, DL, Elikin, PL, Vincent, A, et al. Use of complementary and alternative medical therapies by patients referred to a fibromyalgia treatment program of a tertiary care center. Mayo Clin Proc 2005; 80: 55-60.